GENE ONLINE|News &
Merit Medical Systems Acquires View Point Medical to Expand Interventional Oncology Portfolio
Merit Medical Systems, Inc. has announced the acquisition of View Point Medical, Inc., a move aimed at expanding its therapeutic oncology portfolio. The transaction is expected to enhance Merit Medical’s offerings in the field of interventional oncology, further strengthening its position in this specialized area of medical technology.
View Point Medical specializes in innovative solutions for oncology procedures, particularly those involving advanced imaging and navigation technologies. By integrating View Point Medical’s expertise and product line into its operations, Merit Medical plans to broaden its capabilities in delivering targeted therapies for cancer treatment. This acquisition aligns with Merit’s ongoing efforts to develop minimally invasive solutions that improve patient outcomes while addressing critical needs within the healthcare sector.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: April 1, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
LATEST
FDA Grants Full Approval to Travere Therapeutics’ FILSPARI as First Medication for Treating FSGS
2026-04-13
High Income Securities Fund Announces Monthly Distribution Schedule for Second Quarter of 2026
2026-04-13
Walker & Dunlop Expands Affordable Housing Team with Addition of Jack Hodgkins and Stacie Nekus
2026-04-13
Aura Minerals Updates 2026 CAPEX Guidance to Include Era Dorada Project Construction Costs
2026-04-13
EVENT
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
